They are turning into (have turned into) the MedMen of Australia.
Cann Group has said it will “vigorously defend” legal proceedings launched by New Zealand-based Rua Bioscience which has accused the cultivator of a breach of contract.
Rua is claiming damages against Cann Group subsidiary Cannoperations for an alleged breach of contractual rights to exclusively sell Cann’s medicinal cannabis products in Australia.
Read full story
Cann Group vows to ‘vigorously’ defend Rua claims as contract dispute goes legal
